Apr 18, 2024

Which ASX companies are resurrecting abandoned drugs? Part 3

"SPL has developed its proprietary Dendrimer Enhanced Products platform (DEP) to improve the effectiveness and safety of drugs, especially cancer treatments." Read the full article in Stockhead. 

 This contains certain forward-looking statements.